Both in Pharmaceuticals
Ensysce Biosciences vs Soligenix
Over the past year ENSC returned −79.0% and SNGX returned −76.5%; their daily moves had a correlation of 0.05.
ENSC −79.0% SNGX −76.5%Growth of $1, one year, split-adjusted
| Metric | ENSC | SNGX |
|---|---|---|
| Price | $0.4380 | $0.3693 |
| Market cap | $8.5M | $8.0M |
| Today | −3.16% | −1.55% |
| 1 month | +5.3% | +2.0% |
| 6 months | +17.9% | +7.0% |
| Year to date | −52.4% | −72.4% |
| 1 year | −79.2% | −76.3% |
| Revenue growth (YoY) | −15.1% | — |
| Gross margin | 100.0% | — |
| Net margin | −220.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.9× | — |
| Net cash | $479.9K | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 121.6% | 41.4% |
| Short % of float | 2.1% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).